In situ hybridization (ISH) is a type of hybridization that uses a labeled complementary DNA, RNA or modified nucleic acids strand to localize a specific DNA or RNA sequence in a portion or section of tissue (in situ), or, if the tissue is small enough, in the entire tissue, in cells, and in circulating tumor cells (CTCs). This is distinct from immunohistochemistry, which usually localizes proteins in tissue sections.
North America is expected to account for the largest share of the market in 2018. This can be attributed to growing clinical and research in cancer by biotechnology and pharmaceutical companies, government initiatives, increasing prevalence and diagnosis of cancer in the U.S. and Canada, and increasing adoption of companion diagnostics. Increased adoption of companion diagnostics is attributed to the development and launch of newer therapeutic agents. However, the Asia-Pacific region is expected to grow at the highest CAGR during the forecast period. This can be attributed to the growing presence of international players in China and India, increasing cancer prevalence and diagnosis, and increased healthcare expenditure across the Asia-Pacific region are drivers for the in situ hybridization market in this region.
In 2018, the global In situ Hybridization market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global In situ Hybridization status, future forecast, growth opportunity, key market and key players. The study objectives are to present the In situ Hybridization development in United States, Europe and China.
The key players covered in this study
Abbott Laboratories
Roche
Thermo Fisher Scientific
Merck
Agilent Technologies
Perkin Elmer
Danaher
Exiqon
Biogenex Laboratories
Advanced Cell Diagnostics
Bio Sb
Market segment by Type, the product can be split into
Fluorescence In Situ Hybridization (FISH)
Chromogenic In Situ Hybridization
Market segment by Application, split into
Cancer Diagnosis
Immunology
Neuroscience
Cytology
Infectious Diseases
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global In situ Hybridization status, future forecast, growth opportunity, key market and key players.
To present the In situ Hybridization development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of In situ Hybridization are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Summary:
Get latest Market Research Reports on In situ Hybridization. Industry analysis & Market Report on In situ Hybridization is a syndicated market report, published as Global In situ Hybridization Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of In situ Hybridization market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.